Table 1: Clinical findings, therapy and follow-up in 10 patients with folliculotropic mycosis fungoides.

Case	Age at diagnosis (years)	Duration skin lesions before diagnosis (years)	Sex	Clinical presentation	Location	Stage at diagnosis	Progression	Initial treatment	CR to initial treatment	Other therapies	Outcome
1	45	2	M	Infiltrated plaques, follicular prominence, alopecia, nodules, later tumors,	Trunk, face, genital, extremities	IA-B	Yes, tumor	PUVA	NA	Local RT, interstitial RT, electron beam RT, BCNU, topical steroids	ASD
2	70	2	F	Patches, infiltrated plaques, nodule, follicular prominence	Arms, face, buttocks	IA-B	No	BCNU	No	Local RT, topical steroids, PUVA	ASD
3	45	13	M	Patches, Infiltrated plaques, follicular prominence, tumors, comedo-like lesions, alopecia	Face, scalp, trunk, extremities, buttocks and genital	IVA (T3N3M0)	Yes, erythrodermic MF	CHVmP-BV	Yes , with recurrence 1 year later	PUVA, total skin RT, local RT, MOPP, chlorambucil-prednisone, acitretin, prednisone	DOL
4	45	19	M	Infiltrated plaques, alopecia, follicular papules	Legs, trunk, arms	IA-B	No	BCNU	Yes	PUVA, IFNalpha	NED
5	38	11	M	Infiltrated plaques, patches, follicular prominence, later nodule and tumors	Face and neck, extremities, trunk	IA-B	Yes, tumor, nodal involvement	PUVA and BCNU	No	Topical steroids, IFN alpha, isotretinoin, Total skin RT, chlorambucil-prednisone, bexarotene	APD
6	34	11	M	Patches, follicular papules, pustular, nodule, comedo-like lesions, alopecia	Face and neck	IA	No	PUVA	No	Topical steroids, isotretinoin, BCNU, local RT, topic tacrolimus	ASD
7	18	1	F	Infiltrated plaques, later alopecia and tumors	Trunk, then generalized	IA-B	Yes, tumor, nodal involvement	Isotretinoin	No	PUVA, BCNU, IFN alpha, topical steroids, chlorambucil-prednisone, bexarotene, promace-MOPP, Steroids, RT, study medication	DOL
8	39	13	M	Patches, infiltrated plaques, hypopigmentation, alopecia, comedo-like lesions	Legs, then generalized	IA-B	No	PUVA	NA	BCNU	ASD
9	63	4	M	Patches, infiltrated plaques, follicular papules, alopecia	Trunk, extremities, buttocks	IA-B	No	PUVA	No	Topical steroids, BCNU	ASD
10	71	12	M	Patches, infiltrated plaques, follicular prominence, nodule, alopecia, comedo-like lesions	Trunk, extremities, genital, face, scalp	IA-B	Yes, nodal involvement and lung involvement	PUVA	No	IFN alpha, topical steroids, BCNU, CHOP	DOL

M = Male, F = Female; NA = Not available; CR = Complete remission; RT = Radiotherapy; PUVA = Psoralen + UVA; BCNU = Chlormustine or bis-chloronitrosourea; CHVmP-BV = Cyclophosphamide, doxorubicin, teniposide and prednisone with bleomycin and vincristine; CHOP = Cyclophosphamide, hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and prednisone; MOPP = Mustargen, Oncovin (vincristine), Procarbazine, Prednisone; ASD = Alive with stable disease; NED = No evidence of disease; APD = Alive with progressive disease; DOL = Died of lymphoma progression